Document vyN7ZNNp7zGDJkxEk6zMkZ906

Managers' Notice No. 934 March 13, 1974 Subject: MEDICAL RESEARCH The University of Louisville is making the following news release this afternoon: LOUISVILLE, Ky., March 13 -- A medical research program on angio sarcoma and related liver abnormalities is being organized by the University of Louisville's Health Sciences Center and Cancer Center under a grant from The B.F.Goodrich Company. Details of the program and Goodrich support for it were announced at a news conference today by Harold Boyer, D.D.S., Vice President for Health Affairs, University of Louisville. "This grant affords the opportunity to serve our community by bringing to bear our already-existing scientific expertise and research methods in regard to the apparent occupational health problem that has developed here in recent weeks," Dr. Boyer said. "It is our goal to provide medical information that can be applied practically in the detection and treatment of liver ailments that may have resulted from worker exposure to vinyl chloride." Specific objectives have been established for the program, according to Arthur H. Keeney, M.D. , D.Sc. , Dean of the School of Medicine, They are: * to develop and implement medical examination and screening procedures. * to establish a registry which will be a computerized data bank containing all information pertinent to incidences of liver disease and angiosarcoma. * to conduct clinical research and basic research programs directly related to the problem of angiosarcoma and related liver diseases through existing Cancer Center procedures. "The first year of the program will cost an estimated $300,000" said Keeney, "and will be funded to this amount by The B.F.Goodrich Company. However, it is conceivable that this program would lead to expanded medical studies on angiosarcoma and other liver diseases, for which broader, additional support from various sources would be sought, as necessary." "We will appoint a clinical coordinator for this project, establish a project office and set up review boards composed of medical and scientific specialists to review progress and procedures being used," he said. 24067001 BFG29322 (over)